Aakash Desai to Rituximab
This is a "connection" page, showing publications Aakash Desai has written about Rituximab.
Connection Strength
0.093
-
Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma. Oncologist. 2017 05; 22(5):549-553.
Score: 0.093